- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01570374
Internet-based Treatment of Generalized Anxiety Disorder
October 31, 2016 updated by: Per Carlbring, PhD, Umeå University
The purpose of this study is to determine whether internet-administered cognitive behavior therapy is a feasible treatment for generalized anxiety disorder.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
103
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Västerbotten
-
Umeå, Västerbotten, Sweden, 90181
- Department of Psychology, Umeå University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Satisfy DSM-IV criteria for generalized anxiety disorder
- Living in Sweden and being able to read Swedish
- Access to computer with internet connection
Exclusion Criteria:
- Currently receiving other psychological treatment
- Non-stable use of psychoactive medication
- Deemed suicidal
- Deemed to suffer from other psychological disorder, e.g. psychosis, bipolarity etc.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: iCBT
Receives treatment.
|
9 week internet-administered, therapist-assisted, controlled-progression cognitive behavioral therapy (iCBT).
Individualized and disorder-specific.
|
NO_INTERVENTION: Waiting list control group
The waiting list control group initially receives no treatment, but do weekly screenings.
After 9 weeks, the control group receives the same treatment as the other study arm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in Penn State Worry Questionnaire (PSWQ)
Time Frame: 24 hours
|
Measures anxiety symptoms related to Generalized Anxiety Disorder.
16 items.
|
24 hours
|
Change from baseline in Penn State Worry Questionnaire (PSWQ)
Time Frame: 6 months
|
Measures anxiety symptoms related to Generalized Anxiety Disorder.
16 items.
|
6 months
|
Change from baseline in Penn State Worry Questionnaire (PSWQ)
Time Frame: 12 months
|
Measures anxiety symptoms related to Generalized Anxiety Disorder.
16 items.
|
12 months
|
Change from baseline in Penn State Worry Questionnaire (PSWQ)
Time Frame: 24 months
|
Measures anxiety symptoms related to Generalized Anxiety Disorder.
16 items.
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in Beck Anxiety Inventory (BAI)
Time Frame: 24 hours
|
21 item rating scale for anxiety symptoms.
|
24 hours
|
Change from baseline in Beck Anxiety Inventory (BAI)
Time Frame: 6 months
|
21 item rating scale for anxiety symptoms.
|
6 months
|
Change from baseline in Beck Anxiety Inventory (BAI)
Time Frame: 12 months
|
21 item rating scale for anxiety symptoms.
|
12 months
|
Change from baseline in Beck Anxiety Inventory (BAI)
Time Frame: 24 months
|
21 item rating scale for anxiety symptoms.
|
24 months
|
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 24 hours
|
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play.
The QOLI test is a measure of positive psychology and positive mental health.
|
24 hours
|
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 6 months
|
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play.
The QOLI test is a measure of positive psychology and positive mental health.
|
6 months
|
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 12 months
|
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play.
The QOLI test is a measure of positive psychology and positive mental health.
|
12 months
|
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 24 months
|
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play.
The QOLI test is a measure of positive psychology and positive mental health.
|
24 months
|
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time Frame: 24 hours
|
9-item depression rating scale.
|
24 hours
|
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time Frame: 6 months
|
9-item depression rating scale.
|
6 months
|
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time Frame: 12 months
|
9-item depression rating scale.
|
12 months
|
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time Frame: 24 months
|
9-item depression rating scale.
|
24 months
|
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: Weekly during treatment period
|
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire.
The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.
The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
|
Weekly during treatment period
|
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: 24 hours
|
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire.
The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.
The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
|
24 hours
|
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: 6 months
|
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire.
The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.
The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
|
6 months
|
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: 12 months
|
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire.
The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.
The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
|
12 months
|
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: 24 months
|
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire.
The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.
The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
|
24 months
|
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: Weekly during treatment period
|
7-item screening form for Generalized Anxiety Disorder.
|
Weekly during treatment period
|
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 24 hours
|
7-item screening form for Generalized Anxiety Disorder.
|
24 hours
|
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 6 months
|
7-item screening form for Generalized Anxiety Disorder.
|
6 months
|
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 12 months
|
7-item screening form for Generalized Anxiety Disorder.
|
12 months
|
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 24 months
|
7-item screening form for Generalized Anxiety Disorder.
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (ACTUAL)
January 1, 2016
Study Completion (ACTUAL)
February 1, 2016
Study Registration Dates
First Submitted
March 31, 2012
First Submitted That Met QC Criteria
April 3, 2012
First Posted (ESTIMATE)
April 4, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
November 1, 2016
Last Update Submitted That Met QC Criteria
October 31, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Oroshjalpen
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Generalized Anxiety Disorder
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
-
Xijing HospitalRecruitingGeneralized Anxiety DisorderChina
-
Sichuan Jishengtang Pharmaceutical Co., Ltd.Not yet recruitingGeneralized Anxiety Disorder
-
Hospital de Clinicas de Porto AlegreRecruitingGeneralized Anxiety DisorderBrazil
-
University of California, Los AngelesMedical University of South Carolina; Massachusetts General HospitalRecruitingGeneralized Anxiety DisorderUnited States
-
Shahid Beheshti University of Medical SciencesCompletedGeneralized Anxiety DisorderIran, Islamic Republic of
-
Dr. Nazanin AlaviOnline PsychoTherapy ClinicCompletedGeneralized Anxiety DisorderCanada
-
Laureate Institute for Brain Research, Inc.National Institute of Mental Health (NIMH)CompletedGeneralized Anxiety DisorderUnited States
-
The Canadian College of Naturopathic MedicineMassachusetts General Hospital; McGill University; Mitacs; Ekhagastiftelsen; Netherlands... and other collaboratorsActive, not recruitingGeneralized Anxiety DisorderCanada
Clinical Trials on Internet-based cognitive behavioral therapy (iCBT)
-
Karolinska InstitutetDeakin UniversityRecruiting
-
Linkoeping UniversityRecruitingAnxiety Symptoms | Depression SymptomsSweden
-
Region of Southern DenmarkUniversity of AarhusRecruitingAnxiety DisordersDenmark
-
University of AarhusUniversity of Southern DenmarkCompletedAnxiety DisordersDenmark
-
Karolinska InstitutetCompletedObsessive-compulsive DisorderSweden
-
Karolinska InstitutetRegion StockholmRecruiting
-
Vilnius UniversityActive, not recruitingSleep | Tinnitus | Depression, Anxiety | Distress, EmotionalLithuania
-
Linkoeping UniversityCompletedDepressive Symptoms | Depressive Disorder, MajorSweden
-
Örebro County CouncilKarolinska InstitutetCompleted
-
Karolinska InstitutetVastra Gotaland Region; Region StockholmActive, not recruiting